Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|February 1, 1983
Preparation and DNA-binding properties of substituted triostin antibioticsA Cornish, K R Fox, M J Waring
Biochimica Et Biophysica Acta|July 5, 1985
Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibioticsK R Fox, C Brassett, M J Waring
British Journal of Pharmacology|September 1, 1980
Interaction between synthetic analogues of quinoxaline antibiotics and nucleic acids: role of the disulphide cross-bridge and D-amino acid centres in des-N-tetramethyl-triostin AK R Fox, R K Olsen, M J Waring
The Biochemical Journal|May 1, 1987
Sequence-selective binding of phleomycin to DNAK R Fox, G W Grigg, M J Waring
Anti-Cancer Drug Design|April 1, 1986
DNA sequence selectivity of three biosynthetic analogues of the quinoxaline antibioticsC M Low, K R Fox, M J Waring
Biochimica Et Biophysica Acta|March 29, 1982
Equilibrium and kinetic studies on the binding of des-N-tetramethyltriostin A to DNAK R Fox, R K Olsen, M J Waring
Nucleic Acids Research|March 11, 1987
DNA sequence preferences for an intercalating porphyrin compound revealed by footprintingK Ford, K R Fox, S Neidle, et al.
The Biochemical Journal|December 1, 1980
Binding of quinoline analogues of echinomycin to deoxyribonucleic acid. Role of the chromophoresK R Fox, D Gauvreau, D C Goodwin, et al.
The Biochemical Journal|June 1, 1983
The use of radiolabelled triostin antibiotics to measure low levels of binding to deoxyribonucleic acidK R Fox, A Cornish, R C Williams, et al.
FEBS Letters|July 7, 1986
DNA sequence preferences for the anti-cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprintingK R Fox, M J Waring, J R Brown, et al.
Pageof 29